The amount of the deal was not disclosed.
Developed by Benjamin Glick, Ph.D., a professor at the University of Chicago, SnapGene provides tools to plan, visualize, and document molecular biology procedures. SnapGene desktop software is used in more than sixty-five countries, in virtually every major research institution, and in the largest pharmaceutical and biotech companies worldwide.
A parent entity, Insightful Science, was formed to support the growing portfolio of brands within GraphPad. Led by Thomas Swalla, CEO, Insightful operates software platforms designed to empower scientists at every step of the research and development process. More than 1 million scientists around the globe use its products to advance research and accelerate change.
Products within its portfolio include GraphPad Prism, Geneious DNA data analysis solutions, Geneious Prime and Geneious Biologics, and SnapGene and SnapGene Server.
All the companies within Insightful Science will continue to operate and serve customers under their respective brands.